Turjuman - Translation Services For the Middle East

Enhancing Patient Centricity with Life Sciences Language Solutions

Turjuman language solutions
Aug 09, 2024By Turjuman language solutions

Patient centricity has become a fundamental aspect of successful drug development and commercialization in the life sciences industry. As companies strive to place patients at the heart of their operations, they must address linguistic and cultural challenges that often hinder effective communication. For life sciences companies operating in global markets, accurate and culturally relevant language solutions are essential to meeting patient needs, ensuring compliance, and ultimately achieving market success.

The Role of Patient Centricity in Life Science Services

Patient centricity refers to designing and delivering healthcare solutions, clinical trials, and treatments with the patient’s needs, values, and preferences as the top priority. It’s no longer enough to develop drugs in isolation; companies must engage with patients throughout the drug development cycle, from clinical trials to post-market support. According to a report by Deloitte, 73% of life sciences companies are now focused on improving patient engagement to increase clinical trial participation and improve outcomes.

However, achieving patient centricity across multiple geographies and languages requires more than just an understanding of patient needs. It demands precise, culturally relevant communication that resonates with diverse populations. This is where high-quality language services play a crucial role.

Language Barriers in Life Sciences


Life sciences organizations face significant linguistic challenges when conducting clinical trials and delivering healthcare solutions globally. One of the key issues is the need for multilingual documentation, which must be carefully translated to ensure patient understanding. Mistranslations or cultural misinterpretations in clinical trial protocols, informed consent forms, or patient-reported outcomes (PROs) can lead to serious consequences, including patient non-compliance, trial delays, or even regulatory rejections.

For instance, a 2018 study published in The New England Journal of Medicine revealed that 25% of clinical trial delays are caused by issues related to language and cultural misunderstandings. This emphasizes the importance of investing in professional language solutions that guarantee accuracy and cultural relevance in healthcare materials.

Turjuman’s Comprehensive Language Solutions for Life Science Services


At Turjuman Language Solutions, we specialize in providing expert language services designed to meet the unique needs of the life sciences sector. Our team of linguists and subject matter experts is experienced in the complexities of clinical research, regulatory compliance, and medical terminology. By combining industry expertise with cutting-edge language technologies, we ensure that every translation is accurate, culturally appropriate, and compliant with global standards.

Key Services We Offer:


1. Translation of Clinical Trial Documentation: We provide precise translations of clinical trial protocols, informed consent forms, and patient-reported outcomes. These translations help ensure that patients fully understand the treatment they are participating in, which is crucial for compliance and trial success.

      • Example: In a multinational clinical trial for a cardiovascular drug, Turjuman successfully translated informed consent forms into 12 languages, ensuring that participants in Europe, the Middle East, and Asia understood the risks and benefits of the study.


2. Patient-Facing Materials: Patient recruitment and retention are critical for clinical trial success. Turjuman helps life sciences companies create clear and compelling patient-facing materials, such as brochures, educational leaflets, and digital content. These materials are designed to foster trust, enhance patient engagement, and increase participation.

    • Statistics: According to the Center for Information & Study on Clinical Research Participation (CISCRP), 85% of clinical trials fail to retain enough patients. With culturally sensitive patient materials, we help life sciences companies address this challenge by creating materials that resonate with target audiences.


3. Regulatory Compliance: Regulatory authorities like the FDA and EMA have stringent requirements for language accuracy in clinical trial submissions and product labeling. Turjuman’s expert translators ensure compliance with global regulatory standards, helping companies mitigate risks and avoid costly delays.

    • Example: In a recent project, Turjuman helped a pharmaceutical company secure FDA approval for a new drug by providing certified translations of product labeling and regulatory documents, ensuring compliance with U.S. regulatory requirements.


4. Advanced Language Technologies: At Turjuman, we leverage advanced language technologies, including translation memory tools and machine translation with post-editing (MTPE), to streamline the translation process and reduce turnaround times without sacrificing quality. Our use of these tools enables us to maintain consistency across large volumes of text, ensuring that key terminology and regulatory requirements are accurately reflected in life science services.

    • Statistics: The use of translation memory tools can reduce translation costs by up to 30% and improve consistency by reusing previously translated content across documents, as reported by the Common Sense Advisory.


Benefits of Partnering with Turjuman


By choosing Turjuman as your language partner, you can enjoy a range of benefits that directly support your patient-centric goals:

1. Enhanced Patient Engagement
With precise and culturally relevant translations, Turjuman helps life sciences companies create patient-facing materials that foster trust, improve comprehension, and boost engagement. This is crucial for clinical trials, where clear communication is essential for patient retention and compliance.

2. Accelerated Clinical Trial Timelines
By reducing translation turnaround times, we help companies accelerate their clinical trials. Turjuman’s rigorous quality assurance processes ensure that fast delivery does not come at the cost of accuracy. This allows companies to meet their trial timelines without compromising on quality.

3. Regulatory Risk Mitigation
Accurate and compliant translations help companies mitigate the risks associated with regulatory submissions. Turjuman’s team of expert translators understands the nuances of local regulations, ensuring that your submissions meet the required standards.

4. Optimized Market Access
In addition to clinical trial support, Turjuman also assists companies with market access by translating product labeling, marketing materials, and patient education content. This ensures that your products are well-received in diverse markets, driving better engagement and sales.

Example: Turjuman worked with a global pharmaceutical company to translate and localize marketing materials for a new diabetes medication, ensuring the messaging resonated with patients in five Middle Eastern countries.


Conclusion:

Empower Patient-Centric Success with Turjuman
At Turjuman Language Solutions, we are committed to helping life sciences companies drive patient-centric success through accurate and culturally sensitive translations. Our comprehensive suite of language services is designed to meet the unique challenges of the life sciences sector, ensuring that patients are at the heart of every communication.

Whether you need translations for clinical trials, patient materials, or regulatory documents, Turjuman’s expert linguists and advanced technologies can help you streamline your processes, enhance patient engagement, and speed up your time to market.

Partner with us today and take the first step toward empowering your life sciences success. Contact Turjuman Language Solutions to learn more about our services and how we can support your patient-centric goals.

Partner with Turjuman today and put patients at the center of your drug development journey. Let us help you build stronger patient connections, enhance clinical trial outcomes, and speed up your time to market. Empower your success—contact us now to get started!